Table 1 Characteristics of AEGIS study participants by sex.

From: Glucodensity functional profiles outperform traditional continuous glucose monitoring metrics

 

Men \((n=220)\)

Women \((n=361)\)

p-value (t-test)

Age, years

\(47.8\pm 14.8\)

\(48.2\pm 14.5\)

0.04

A1c, %

\(5.6\pm 0.9\)

\(5.5\pm 0.7\)

0.26

FPG mg/dL

\(97\pm 23\)

\(91\pm 21\)

\(<0.001\)

HOMA-IR \(mg/dL.\mu UI/m\)

\(3.97\pm 5.56\)

\(2.74\pm 2.47\)

\(<0.001\)

BMI \(kg/m^2\)

\(28.9\pm 4.7\)

\(27.7\pm 5.3\)

\(<0.001\)

CONGA mg/dL

\(0.88\pm 0.40\)

\(0.86\pm 0.36\)

0.03

MAGE mg/dL

\(33.6\pm 22.3\)

\(31.2 \pm 14.6\)

\(<0.001\)

MODD

\(0.84\pm 0.58\)

\(0.77\pm 0.33\)

\(<0.001\)

  1. Mean ± standard deviation are shown. BMI - body mass index; FPG - fasting plasma glucose; A1c - glycated haemoglobin; \(HOMA-IR\) - homeostasis model assessment-insulin resistance; CONGA - glycemic variability in terms of continuous overall net glycemic action; MODD - mean of daily differences; MAGE - mean amplitude of glycemic excursions.